tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference call
1M ago
enGene price target lowered to $18 from $19 at Morgan Stanley
Premium
The Fly
enGene price target lowered to $18 from $19 at Morgan Stanley
2M ago
Buy Rating for enGene Holdings: Strategic Positioning and Competitive Edge in NMIBC Market
Premium
Ratings
Buy Rating for enGene Holdings: Strategic Positioning and Competitive Edge in NMIBC Market
2M ago
enGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy
PremiumCompany AnnouncementsenGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy
2M ago
enGene achieves target enrollment in LEGEND trial of detalimogene voraplasmid
Premium
The Fly
enGene achieves target enrollment in LEGEND trial of detalimogene voraplasmid
2M ago
enGene Holdings to Engage in September Investor Conferences
Premium
Company Announcements
enGene Holdings to Engage in September Investor Conferences
2M ago
Optimistic Buy Rating for enGene Holdings Amid LEGEND Study Progress and Regulatory Advancements
PremiumRatingsOptimistic Buy Rating for enGene Holdings Amid LEGEND Study Progress and Regulatory Advancements
5M ago
enGene price target lowered to $19 from $34 at Morgan Stanley
Premium
The Fly
enGene price target lowered to $19 from $34 at Morgan Stanley
5M ago
enGene Holdings Reports Q2 2025 Financial Results
Premium
Company Announcements
enGene Holdings Reports Q2 2025 Financial Results
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100